반응식
I[C:2]1[CH:7]=[CH:6][C:5]([C:8]2[O:9][C:10]([CH3:13])=[N:11][N:12]=2)=[CH:4][CH:3]=1.N1([C:20]2[CH:21]=[C:22]([NH:26][C:27]([C:29]3[CH:30]=[C:31](C4C=CC(C5N=C(C)ON=5)=CC=4C)[C:32]([CH3:35])=[CH:33][CH:34]=3)=[O:28])[CH:23]=[CH:24][CH:25]=2)CCOCC1.C[CH:50]([OH:52])C>>[CH3:50][O:52][C:20]1[CH:21]=[C:22]([NH:26][C:27]([C:29]2[CH:34]=[C:33]([C:2]3[CH:7]=[CH:6][C:5]([C:8]4[O:9][C:10]([CH3:13])=[N:11][N:12]=4)=[CH:4][CH:3]=3)[C:32]([CH3:35])=[CH:31][CH:30]=2)=[O:28])[CH:23]=[CH:24][CH:25]=1참가 물질
4
반응물 3
생성물 1
실험 절차
Example 37 was prepared using 2-(4iodophenyl)-5-methyl-[1,3,4]oxadiazole (Intermediate 15) and N-3-methoxy-phenyl)-4-methyl-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide (Intermediate 6) with propan-2-ol as the solvent.
후처리
- customExample 37 was prepared
출처 및 근거
- ORD 기록
- ord-f0dfb40fb3f24125ae27a4c2b4130b0b
- 출처 데이터셋
- uspto-grants-2008_09
- 특허 번호
- US07425555B2
연결된 노트
불러오는 중…